Branded Legacy Inc. (OTC:BLEG) Stock On The Radar After Acquisition News

The pharmaceutical biotechnology sector has naturally attracted a lot of attention in recent times, owing to the innovative approach of the sector as a whole. Investors are always on the lookout for options in that particular niche, and a company that may be worth looking into is Branded Legacy Inc. (OTC:BLEG). On January 9, the company was in the news after it announced that it had completed the strategic acquisition of the firm All In Extracts, Inc. All In Extracts was described as an innovative company involved in medicinal ethnobotany.

Additionally, the company went on to note that the landmark deal would further boost the company’s commitment towards collaborative growth, expansion, and innovation in the biotech space. In this context, it could be a good idea for investors to get a better idea of all-in-one extracts. It is based out of Tampa, Florida, and is best known for its advanced products, which have almost always been path-breaking offerings in the wellness and health industries.

Branded Legacy is based out of Melbourne, Florida, and is particularly well-known for having high-level expertise in the fields of marketing, branding, and distribution strategies. These strategies helped create strong momentum in the product sales of The Alcannabist. In the news release, it was also noted that the two companies shared a common philosophy that was based on recognizing collaboration as the basis of success.

The combination of the two companies could lead to a revolution in the biotech industry, it was asserted. David Oswald, the Chief Executive Officer of Branded Legacy, spoke about the acquisition as well. He stated that right at the moment that he had met the All in Extracts team, there had been a recognition of the possibilities that could be unlocked if the two joined forces.

Ian Leigh

Ian Leigh is a specialist in analyzing stocks, SEC and OTC filings, and financials of public and privately-held companies. He has played a significant role in M&A activity, consulting with publicly-held firms on acquisitions and divestitures. He also consults on valuations and branding. He lectures at major universities and teaches at specialty financial schools.